0.581  -0.081 (-12.24%)		02-12 16:00
Open: 0.6708 High: 0.7199 Volume: 991,478		Pre. Close: 0.662 Low: 0.5806 Market Cap: 73(M)

Short term
Mid term
Targets	6-month :	14.65	1-year :	23.3
Resists	First :	12.55	Second :	19.95
Pivot price	1.59
Supports	First :	0.58	Second :	0.48
MAs	MA(5) :	0.68	MA(20) :	3.46
	MA(100) :	2.96	MA(250) :	1.51
MACD	MACD :	-1.7	Signal :	-1.4
%K %D	K(14,3) :	0	D(3) :	0
RSI	RSI(14): 34.8
52-week	High :	19.95	Low :	0.3

Price has closed below its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is BEARISH in short-term; and NEUTRAL in mid-long term.
[ NBY ] has closed above bottom band by 27.1%. Bollinger Bands are 9.9% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

If tomorrow:	Open lower	Open higher
High:	0.7 - 0.7	0.7 - 0.7
Low:	0.57 - 0.58	0.58 - 0.58
Close:	0.57 - 0.58	0.58 - 0.59

NovaBay Pharmaceuticals, Inc., a pharmaceutical company, develops and sells eyecare and skincare products in the United States and internationally. It offers Avenova, a solution for removing foreign materials, including microorganisms and debris from skin around the eye, such as the eyelid; and wound care products under the NeutroPhase and PhaseOne brands. The company also provides dermatological solutions to address skincare concerns comprising keratosis pilaris, rosacea and eczema, anti-aging, SPF, hyperhidrosis, excessive hair, and acne under the DERMAdoctor brand. It sells its products through retailers, digital beauty channels, and distributors, as well as online. The company was formerly known as NovaCal Pharmaceuticals, Inc. and changed its name to NovaBay Pharmaceuticals, Inc. in February 2007. NovaBay Pharmaceuticals, Inc. was incorporated in 2000 and is headquartered in Emeryville, California.

Thu, 12 Feb 2026
NovaBay Pharma Announces 1-for-5 Reverse Stock Split - TipRanks

Thu, 12 Feb 2026
Reverse split shrinks NovaBay (NYSE: NBY) share count fivefold - Stock Titan

Thu, 12 Feb 2026
NovaBay Pharmaceuticals Announces 1-for-5 Reverse Stock Split - TradingView

Tue, 10 Feb 2026
Massive warrant deals and share increase at NovaBay (NYSE: NBY) head to vote - Stock Titan

Tue, 20 Jan 2026
NovaBay Pharmaceuticals enters $100 million at-the-market sales agreement - Investing.com

Tue, 20 Jan 2026
NovaBay falls on deal for $100M stock (update) (NBY:NYSE) - Seeking Alpha

Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.	Underperform
Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).	Neutral
Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.	Outperform
Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.	Outperform
Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.	Outperform
Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.	Underperform

Exchange: AMEX
Sector: Healthcare
Industry: Biotechnology
Shares Out	0 (M)
Shares Float	0 (M)
Held by Insiders	0 (%)
Held by Institutions	0 (%)
Shares Short	0 (K)
Shares Short P.Month	0 (K)

EPS	0
EPS Est Next Qtrly	0
EPS Est This Year	0
EPS Est Next Year	0
Book Value (p.s.)	0
Profit Margin	0 %
Operating Margin	0 %
Return on Assets (ttm)	0 %
Return on Equity (ttm)	0 %
Qtrly Rev. Growth	0 %
Gross Profit (p.s.)	0
Sales Per Share	0
EBITDA (p.s.)	0
Qtrly Earnings Growth	0 %
Operating Cash Flow	0 (M)
Levered Free Cash Flow	0 (M)

PE Ratio	0
PEG Ratio	0
Price to Book value	0
Price to Sales	0
Price to Cash Flow	0

Dividend	0
Forward Dividend	0
Dividend Yield	0%
Dividend Pay Date	Invalid DateTime.
Ex-Dividend Date	Invalid DateTime.